FAQ

BCG Vaccine

Known as: Calmette's Vaccine, Bacillus Calmette Guerin, Bacillius Calmette-Guerin Vaccine 
A vaccine containing bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis, with non-specific immunoadjuvant and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1944-2017
05010019442016

Related topics

Related topics

28 relations

Narrower (3)

BCG, Live, Connaught StrainTheraCysmethanol extraction residue (MER) tubercle bacillus fraction
Bacillus Calmette-GuerinBacillus Calmette-Guerin AntigenBladder NeoplasmBurn injury
(More)

Broader (2)

Immunologic AdjuvantsTuberculosis Vaccines

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
BCG Vaccine
Tuberculosis
Drug Allergy
agonists
Burn injury
Immunologic Deficiency Syndromes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
Tuberculosis vaccine development at a divide.
PURPOSE OF REVIEW Tuberculosis (TB) remains a major health threat that will only be defeated by a combination of better drugs… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Corrigendum: Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells
The variable efficacy of Bacille Calmette Guerin (BCG) vaccination against tuberculosis has prompted efforts to improve the… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Genome plasticity of BCG and impact on vaccine efficacy.
To understand the evolution, attenuation, and variable protective efficacy of bacillus Calmette-Guérin (BCG) vaccines… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
Bacillus Calmette-Guerin (BCG) vaccine has failed to control the global tuberculosis (TB) epidemic, and there is a lack of safe… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia…
Heterologous prime-boost immunization strategies can evoke powerful T cell immune responses and may be of value in developing an… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.
The efficacy of Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccine against pulmonary tuberculosis (TB) varies enormously… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6.
In this study, we investigated the potential of a tuberculosis subunit vaccine based on fusion proteins of the immunodominant… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional…
Tuberculosis (TB) continues to ravage humanity, causing 2 million deaths per year. A vaccine against TB more potent than the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Comparative genomics of BCG vaccines by whole-genome DNA microarray.
Bacille Calmette-Guérin (BCG) vaccines are live attenuated strains of Mycobacterium bovis administered to prevent tuberculosis… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
BACKGROUND The candidate vaccines against malaria are poorly immunogenic and thus have been ineffective in preventing infection… (More)
Is this relevant?